Many children experience pre-school or early childhood wheezing. In a significant proportion symptoms disappear as the child grows, but others have persistent and troublesome asthma 10 which can be life-long. Tools to predict course of disease in young children are a priority for families and clinicians. This review summarizes evidence from several longitudinal population-based birth-cohort studies that have identified risk factors for persistence and remission of childhood asthma. These factors include clinical characteristics, environmental and other exposures, familial factors, biomarkers of allergic inflammation, measurements of 15 lung function and airway responsiveness, and genetic variants. This review also introduces the concept of polygenic risk and genetic risk scores, and describes results from a recent study that suggests promise for the use of genetic information in predicting the course of childhood asthma. We conclude with a discussion of implications and future directions.
Many children experience pre-school or early childhood wheezing. In a significant proportion symptoms disappear as the child grows, but others have persistent and troublesome asthma 10 which can be life-long. Tools to predict course of disease in young children are a priority for families and clinicians. This review summarizes evidence from several longitudinal population-based birth-cohort studies that have identified risk factors for persistence and remission of childhood asthma. These factors include clinical characteristics, environmental and other exposures, familial factors, biomarkers of allergic inflammation, measurements of 15 lung function and airway responsiveness, and genetic variants. This review also introduces the concept of polygenic risk and genetic risk scores, and describes results from a recent study that suggests promise for the use of genetic information in predicting the course of childhood asthma. We conclude with a discussion of implications and future directions. Asthma is the commonest chronic noncommu-25 nicable disease of childhood. Prevalence figures vary, but up to 20% of children report recurrent wheezing. In some, early childhood wheezing disappears, but others have persistent and troublesome life-long asthma [1] [2] [3] [4] . Identifica-30 tion of children whose symptoms will persist and who will develop more troublesome disease is a clinical priority. Which children should be more actively treated for asthma in the hope of reducing long-term morbidity? Can we use 35 clinical characteristics, physiological measurements, biomarkers or genetics to more precisely determine outcomes? When can we reassure parents that their child will 'outgrow' asthma? Sensitive and specific tests to determine which 40 children will suffer persistent symptoms and which will recover remain a work in progress, but longitudinal population-based birth cohort studies provide insights into risk factors for persistent disease [3, [5] [6] [7] [8] [9] [10] [11] .
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Sex & age at onset Persistence is more frequent in boys in most longitudinal studies tracking asthma from early to middle childhood [8, 10] , although not all studies find sex differences [9] . In studies with 50 a longer duration of follow-up, asthma persistence after puberty is more frequent in girls [3, 5] . Earlier age of onset is associated with increased risk of asthma persistence. In the Tucson Children's Respiratory Study, asthma onset by 6 years of age and persistent wheezing in early life predicted sevenfold and 14-fold increases in odds of chronic asthma at 22 years of age [5] . In the Dunedin longitudinal study, each 1-year increase in age at asthma onset predicted 11% decrease in the odds of persistent asthma [3] .
Symptom severity
More frequent/severe childhood symptoms predict increased risk of asthma persistence. In a report from Tasmania, only 25% of children continued to wheeze as adults [1] , whereas in a simultaneous report from Melbourne, the rate of persistence was 70% [12] . This discrepancy was due to the Melbourne cohort being 'enriched' with children with more severe asthma [13] . Many studies confirm that more severe symptoms predict a doubling or tripling of the odds of persistence [6, 8, 14, 15] .
Rhinoconjunctivitis & eczema
Rhinoconjunctivitis and eczema increase the likelihood of persistence [14] . In the Tasmanian study, 29.7% of persistent atopic asthma was attributable to concomitant childhood eczema or rhinitis; the combination of these two risk factors predicted a nearly 12-fold increase in the odds of adult atopic asthma [16, 17] 
Special Report
Allergy (PIAMA) study, eczema before the age of 4 years more 55 than doubled the odds that early symptoms would persist to become overt clinical asthma at age 7-8 years [8] .
Allergy Allergic sensitization, a major driver of development of asthma, is also related to persistence of disease [18] . In the German 60 Multicentre Allergy Study (MAS), sensitization to indoor (mite, cat and dog) allergens by the age of 3 years gave a positive predicted value of 57% for asthma at 11-13 years; when exposure to cat, dog or mite allergen before the age of 3 years was in the upper quartile of the distribution in the total MAS 65 population, positive predicted value for persistent asthma was 83% [7] . Early childhood allergic sensitization also predicted diminished lung function and airway hyperresponsiveness (AHR) at ages 7-13 years in the MAS cohort [19] . Allergens of interest differ according to location; in the Tucson cohort, sen-70 sitization to Alternaria alternata by the age of 6 years trebled the odds of chronic asthma at 22 years [5] .
Infection
In the Isle of Wight study, persistence to age 10 years was doubled in those with a history of recurrent chest infections at 75 2 years [20] . In the PIAMA cohort, respiratory tract infections one-to two-times per year between birth and 4 years almost doubled the risk of asthma at age 7-8 years, while ‡3 infections per year almost trebled the risk [8] . Among 198 sensitized children in Perth, the risk of subsequent persis-80 tent wheeze was 49% with three severe lower respiratory tract illnesses in the first 2 years of life, increasing to 75% with six such episodes [21] . Early childhood infections may also predispose to other risk factors for asthma persistence, such as atopy, although whether viral infection is causal of asthma or instead 85 acts to reveal latent disease is uncertain [22] .
Socioeconomic status
In the PIAMA and Generation R cohorts, respectively, medium or low parental education was associated with a 50 and 60% increase in the odds of persistent childhood asthma relative to 90 children with highly educated parents [8, 10] . These associations likely reflect a combination of physical and social environmental factors [23] .
Allergic inflammation
Blood eosinophils have been measured for decades as markers 95 of allergic inflammation and have a modest predictive role with respect to persistent asthma. Eosinophilia >470/mm 3 was a risk factor (p < 0.001) for persistence of wheezing at age 6 in a clinical cohort of infants in France [24] . Blood eosinophilia ‡4% is included in the minor criteria of the Asthma Predictive 100 Index [25] . Measurements of serum IgE from birth onward have often been assessed for their predictive role in the development of asthma but may also predict persistence. In the PIAMA cohort, specific IgE measured at 4 years predicted an almost threefold increase in the odds of wheezing and asthma at 8 years 105 after adjustments for clinical status [26] . In the MAS cohort, elevated total IgE at 3 years in children with wheeze before the age of 3 years trebled the risk of wheezing at 11-13 years [7] .
Lung function
In the Tucson cohort, low airway function at 6 years, defined 110 as flow rates in the lowest quartile of AQ3 VmaxFRC, doubled the risk of chronic asthma at 22 years [5] . Abnormal interrupter resistance measured at age 4 years in PIAMA was associated with wheezing at age 6 years, independently of the clinical history, but not at 7 and 8 years [26] . In the Dunedin cohort, 115 study members with persistent adult asthma were found to have had low lung function from the first measurement at age 9 years, suggesting airflow obstruction developed at a young age in those destined to have persistent disease [3] .
AHR measurements likewise have predictive value. In the 120 Tucson cohort, AHR measured by cold air challenge at 6 years predicted a more than fourfold increase in the odds of chronic asthma at 22 years [5] . In the Dunedin cohort, children with positive methacholine challenges in childhood were at a threefold increased risk of persisting asthma in young adulthood [3] . 125 In the Norwegian birth cohort, AHR at age 10 years appeared to be a weak predictor of persistence at age 16 years [27] . However, the predictive value improved substantially when results were stratified by severity; 54% of those with the greatest degree of AHR (PD 20 £1 mmol) at 10 years had active asthma 130 at 16 years [28] .
Exhaled fraction of Nitric Oxide had predictive value both in relation to onset of new asthma [29] and persistence. In the PIAMA cohort, each AQ4 IQR increase in log10 exhaled fraction of Nitric Oxide measured at 4 years predicted a 60% increase in 135 odds of wheezing and asthma at 8 years, even after adjusting for IgE and clinical history [26] .
Genetics
A positive family history of asthma or atopy is associated with increased risk of asthma persistence. In the PIAMA, Generation 140 R and MAS cohorts, 'any parental asthma' more than doubled the odds of asthma persistence [7, 8, 10] . Evidence is mixed as to whether the sex of the parent with asthma matters to risk of transmission [9, 24] .
Genetic variants discovered in genome-wide association stud-145 ies
AQ5
(GWASs) may also provide prognostic information about the course of asthma. GWASs have identified genes that modulate aspects of the natural history of asthma such as atopy, lung development and susceptibility to more severe disease, suggesting promise for genetic prediction of the course of asthma [30] .
150 GWASs of the course of asthma are not yet feasible because relatively few data exist that follow children into adulthood [31] . GWASs have discovered loci associated with childhood onset of asthma [32] [33] [34] [35] and revealed asthma to be highly polygenicinfluenced by many different genetic factors, each which make 155 small contributions to pathogenesis [36] . A promising approach to studying polygenic conditions is to use 'genetic risk scores' that summarize information from a set of discovered risk variants to produce a continuously distributed index of genetic liability [37] [38] [39] [40] [41] [42] . Because genetic risk scores aggregate information 160 from multiple risk variants, they measure a larger genetic effect and can be studied in much smaller samples than are required for GWAS. Genetic risk scores thus provide an opportunity to test how genetic risks discovered in GWAS relate to persistence of asthma [43] .
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A genetic risk score study of the natural history of asthma at age 38 years has been conducted in the Dunedin cohort [11] . The score used in that study comprised 15 variants discovered in the GABRIEL Consortium asthma GWASs of over 26,000 cases and controls [35] . In the Dunedin cohort, a higher genetic risk 170 score not only predicted asthma with onset early in childhood, atopy and AHR, but also predicted life-course persistence of asthma and development of incompletely reversible airflow obstruction, more days missed from school and work due to asthma and increased likelihood of admission to hospital. Within 175 the 21% of the cohort who had developed asthma by the age of 13 years, those with higher genetic risk were more likely to suffer symptoms through age 38 years; each standard deviation (SD) increase in the genetic risk score predicted a 20% increase in the risk of persistent asthma through midlife.
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The small magnitude of the genetic effect means that even for children with asthma who have very low or very high genetic risk scores, course is uncertain; one in three children with a genetic risk score 2 SDs below the mean may be expected to suffer persistent symptoms, while one in three 185 with a genetic risk score 2 SDs above the mean may be expected to experience remission. Genetic effects were similarly modest for other outcomes. Further, among cohort members who never developed asthma, genetic risk was normally distributed -meaning that a proportion of individuals 190 with very high genetic risk scores never developed asthma.
Therefore, these results require a cautious approach regarding the clinical implementation of genetic testing in asthma care [44] . Additionally, replication is needed of the observations from the Dunedin cohort.
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It is uncertain whether even large increases in GWAS sample size will substantially improve genetic prediction for asthma [45, 46] . The next step in translating GWAS discoveries into tools useful to the clinician is therefore to integrate information about genetics with information about the environment [44, 47] . New evi-200 dence that the 17q21 locus repeatedly replicated in asthma GWAS is made more virulent by childhood exposure to rhinovirus [48] highlights the potential in such gene-environment interaction research. Other promising environments to examine in relation to GWAS discoveries include early-life allergen and 205 microbial exposures, both in cases where evidence for association with asthma is conflicting, such as breastfeeding [49, 50] and dog and cat ownership [51] , and cases where risk and protective effects are well established, such as microbial exposures associated with growing up in a farm environment [52] [53] [54] . As additional 210 gene-environment interactions in asthma are documented, it may be possible to develop algorithms that generate sufficiently sensitive and specific predictions to be useful in the clinic.
Can we currently predict the course of asthma? In 2008, an ERS Task Force proposed a new classification to divide the 215 heterogeneous population with early childhood wheezing into 'episodic (viral) wheeze' and 'multi-trigger wheeze' on the basis of published scientific findings and expert opinion [55] . In a recent analysis of PIAMA study data, Savenije and colleagues [56] found that the ERS taskforce classification showed little corre-220 spondence with wheezing phenotypes derived from longitudinal latent class analysis [57] or hypothesis-based definitions of transient early or persistent wheeze as originally described in the Tucson study [58] . Other published prediction rules to identify preschool children having asthma at school age [25, 59] were con-225 sidered of limited value. The path to improved prediction will require refinement of existing approaches -increasing precision of risk factor definitions, more precise phenotyping with objective measures, combining noninvasive measures with prediction rules -incorporation of novel biomarkers -DNA sequence 230 variants, gene expression and epigenetic marking profiles -and identification and incorporation of interactions among environmental, genetic and phenotypic risk factors [56] .
In conclusion, there is broad agreement among population studies that childhood wheezing that is frequent and severe, 235 and is associated with atopy, impaired lung function and airway hyperresponsiveness, is likely to be persistent throughout childhood and into adulthood. The possibilities of genomic prediction, including genetic risk scores, gene-environment interactions and transcriptomic and epigenetic signatures, are 240 just beginning to be explored. Much more remains to be done before we can, with a high level of confidence, predict on an individual level which children will have persistent asthma.
Expert commentary
Prospective longitudinal studies of population-based birth cohorts 245 have identified a number of risk factors for persistence of childhood asthma. Collectively, these studies indicate that young age at onset, presence of severe symptoms in early childhood, allergic sensitization, respiratory infection and family history of asthma predispose to a persistent course of disease. Algorithms that inte-250 grate risk factor information cannot yet generate accurate predictions of course of disease, nor do the various algorithms that exist agree consistently in their predictions regarding specific cases. Increased precision of risk factor definitions and standardization of phenotyping of asthma may improve algorithm perfor-255 mance. In addition, genetic and genomic studies of asthma are beginning to uncover novel biomarkers of risk for persistent disease. Next steps in improving capacity to predict the course of asthma include integrating these discoveries with established environmental and phenotypic risk factors.
260
Five-year view Rapidly declining cost of genomic assays has enabled a growing number of birth cohort studies to add genomic measurements to their databases. As GWASs and other hypothesis-free methods continue to identify novel genomic markers of disease risk, 265 these measurements will be incorporated into studies that profile Potential to predict the course of childhood asthma Special Report www.expert-reviews.com characteristics of persistent compared with remitting childhood asthma. The addition of genetic information to existing algorithms is likely to improve prediction of the course of childhood asthma incrementally. To achieve substantive advance in the 270 capacity to predict course of childhood asthma, scientific breakthroughs are needed, which elucidate interactions among the genome, disease phenotypes and environmental risk factors.
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Key issues
. Childhood asthma is common. For many children, asthma is a childhood-limited problem, but for others, symptoms persist across the life course.
285 . Risk factors for persistent asthma have been identified from birth cohort studies that follow unselected samples of children over time and track the onset and course of asthma.
. Risk factors for persistent asthma include young age at onset, manifestation of severe symptoms including airway hyperresponsiveness and airflow obstruction in early childhood, rhinoconjunctivitis and eczema, childhood allergic sensitization, respiratory infections and family history of asthma.
290 . Genome-wide association studies have discovered asthma-associated genetic variants and revealed that most of the population carries some degree of genetic risk for asthma, while smaller groups are at especially low or especially high risk.
. Children with asthma who carry higher levels of genetic risk may be predisposed to a persistent course of disease, according to one birth cohort study, although genetic predictions have low sensitivity and specificity.
. Despite efforts to combine information across risk factors, it is not yet possible to predict course of childhood onset asthma with 295 accuracy, and existing predictive algorithms often yield conflicting results.
. More precise definitions of risk factors and standardized approaches to phenotyping asthma are needed to improve accuracy of predictive algorithms.
. Integrating genomic information into prediction algorithms may also improve accuracy, especially if interactions among genomic, phenotypic and environmental factors can be quantified. 
